HZNP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Horizon Therapeutics plc Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Horizon Therapeutics plc (NASDAQ: HZNP) to Amgen Inc. for $116.50 in cash per share is fair to Horizon shareholders. Halper Sadeh encourages Horizon shareholders to click here to learn more about their legal rights…
